167 related articles for article (PubMed ID: 28423495)
1. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.
Macha MA; Rachagani S; Qazi AK; Jahan R; Gupta S; Patel A; Seshacharyulu P; Lin C; Li S; Wang S; Verma V; Kishida S; Kishida M; Nakamura N; Kibe T; Lydiatt WM; Smith RB; Ganti AK; Jones DT; Batra SK; Jain M
Oncotarget; 2017 Mar; 8(13):20961-20973. PubMed ID: 28423495
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell Carcinoma.
Odhiambo DA; Pittman AN; Rickard AG; Castillo RJ; Bassil AM; Chen J; Ravotti ML; Xu ES; Himes JE; Daniel AR; Watts TL; Williams NT; Luo L; Kirsch DG; Mowery YM
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1315-1327. PubMed ID: 38104870
[TBL] [Abstract][Full Text] [Related]
3. Different Impacts of DNA-PK and mTOR Kinase Inhibitors in Combination with Ionizing Radiation on HNSCC and Normal Tissue Cells.
Klieber N; Hildebrand LS; Faulhaber E; Symank J; Häck N; Härtl A; Fietkau R; Distel LV
Cells; 2024 Feb; 13(4):. PubMed ID: 38391917
[TBL] [Abstract][Full Text] [Related]
4. Snail controls the mesenchymal phenotype and drives erlotinib resistance in oral epithelial and head and neck squamous cell carcinoma cells.
Dennis M; Wang G; Luo J; Lin Y; Dohadwala M; Abemayor E; Elashoff DA; Sharma S; Dubinett SM; St John MA
Otolaryngol Head Neck Surg; 2012 Oct; 147(4):726-32. PubMed ID: 22568942
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: time-course gene expression profiles and gene association networks.
Michna A; Schötz U; Selmansberger M; Zitzelsberger H; Lauber K; Unger K; Hess J
Radiat Oncol; 2016 Jul; 11():94. PubMed ID: 27455841
[TBL] [Abstract][Full Text] [Related]
6. Afatinib and its encapsulated polymeric micelles inhibits HER2-overexpressed colorectal tumor cell growth in vitro and in vivo.
Guan SS; Chang J; Cheng CC; Luo TY; Ho AS; Wang CC; Wu CT; Liu SH
Oncotarget; 2014 Jul; 5(13):4868-80. PubMed ID: 24947902
[TBL] [Abstract][Full Text] [Related]
7. The evolving concepts of cancer stem cells in head and neck squamous cell carcinoma.
Shah A; Patel S; Pathak J; Swain N; Kumar S
ScientificWorldJournal; 2014; 2014():842491. PubMed ID: 24574924
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI.
Panek R; Welsh L; Baker LCJ; Schmidt MA; Wong KH; Riddell AM; Koh DM; Dunlop A; Mcquaid D; d'Arcy JA; Bhide SA; Harrington KJ; Nutting CM; Hopkinson G; Richardson C; Box C; Eccles SA; Leach MO; Robinson SP; Newbold KL
Clin Cancer Res; 2017 Aug; 23(15):4233-4241. PubMed ID: 28314789
[No Abstract] [Full Text] [Related]
9. Cancer stem cells in head and neck squamous cell carcinoma and its associated markers: A review.
Mallika L; Rajarathinam M; Thangavel S
Indian J Pathol Microbiol; 2024 Apr; 67(2):250-258. PubMed ID: 38394427
[TBL] [Abstract][Full Text] [Related]
10. Activation of oncogenic signaling kinase PAK1 by ionising radiation confers an aggressive phenotype in head and neck squamous cell carcinoma.
Surabhi RP; Rajendran S; Srikanth Swamy Swaroop B; Murugan S; Shanmugasundaram G; Joseph LD; Pitani R; Babu PS; Suresh K R; Venkatraman G
Cell Signal; 2023 Dec; 112():110910. PubMed ID: 37777103
[TBL] [Abstract][Full Text] [Related]
11. The biomarkers for maintenance Cancer stem cell features can be applicable in precision medicine of head and neck squamous cell carcinoma.
Shayan N; Ghiyasimoghaddam N; Mirkatuli HA; Baghbani M; Ranjbarzadhagh Z; Mohtasham N
J Stomatol Oral Maxillofac Surg; 2024 Apr; ():101906. PubMed ID: 38688401
[TBL] [Abstract][Full Text] [Related]
12. Radiation-induced signaling pathways that promote cancer cell survival (review).
Hein AL; Ouellette MM; Yan Y
Int J Oncol; 2014 Nov; 45(5):1813-9. PubMed ID: 25174607
[TBL] [Abstract][Full Text] [Related]
13. Lactate-driven type I collagen deposition facilitates cancer stem cell-like phenotype of head and neck squamous cell carcinoma.
Sun Y; Chen Y; Zhao H; Wang J; Liu Y; Bai J; Hu C; Shang Z
iScience; 2024 Apr; 27(4):109340. PubMed ID: 38500829
[TBL] [Abstract][Full Text] [Related]
14. Correction to "Snail Controls the Mesenchymal Phenotype and Drives Erlotinib Resistance in Oral Epithelial and Head and Neck Squamous Cell Carcinoma Cells".
Otolaryngol Head Neck Surg; 2024 May; ():. PubMed ID: 38796733
[No Abstract] [Full Text] [Related]
15. Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/β-catenin signaling.
Ahmad R; Kumar B; Chen Z; Chen X; Müller D; Lele SM; Washington MK; Batra SK; Dhawan P; Singh AB
Oncogene; 2017 Nov; 36(47):6592-6604. PubMed ID: 28783170
[TBL] [Abstract][Full Text] [Related]
16. Hydration effects on the efficacy of the Epidermal growth factor receptor kinase inhibitor afatinib.
Kannan S; Pradhan MR; Tiwari G; Tan WC; Chowbay B; Tan EH; Tan DS; Verma C
Sci Rep; 2017 May; 7(1):1540. PubMed ID: 28484248
[TBL] [Abstract][Full Text] [Related]
17. Recent Management of Patients with Advanced Epidermal Growth Factor Receptor Mutation Non-small Cell Lung Cancer: Role of Afatinib and Lesson Learned for Developing Countries.
Amin Z; Jayalie VF; Rajabto W
Acta Med Indones; 2017 Jan; 49(1):79-88. PubMed ID: 28450659
[TBL] [Abstract][Full Text] [Related]
18. Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial.
Paz-Ares L; Tan EH; O'Byrne K; Zhang L; Hirsh V; Boyer M; Yang JC; Mok T; Lee KH; Lu S; Shi Y; Lee DH; Laskin J; Kim DW; Laurie SA; Kölbeck K; Fan J; Dodd N; Märten A; Park K
Ann Oncol; 2017 Feb; 28(2):270-277. PubMed ID: 28426106
[TBL] [Abstract][Full Text] [Related]
19. Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway.
Jahan R; Macha MA; Rachagani S; Das S; Smith LM; Kaur S; Batra SK
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2538-2549. PubMed ID: 29777904
[TBL] [Abstract][Full Text] [Related]
20. Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models.
Martinez-Cruzado L; Tornin J; Rodriguez A; Santos L; Allonca E; Fernandez-Garcia MT; Astudillo A; Garcia-Pedrero JM; Rodriguez R
Neoplasia; 2017 Jun; 19(6):460-470. PubMed ID: 28494349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
